Jefferies Remains a Buy on Eli Lilly and Company (LLY)
Lilly(US:LLY) Yahoo Finance·2026-03-29 20:15Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,300. The rating is based on the company’s prescription data for GLP-1 medications. Oral Wegovy had roughly 89,300 IMS prescriptions and 76,800 Symphony prescriptions in the 10th week of its launch. The data outpace comparable launches of injectable Wegovy and Zepbound. On the other hand, data from other GLP-1 drugs witnessed ...